Literature DB >> 29278802

Non-equilibrium atmospheric pressure plasma as innovative method to crosslink and enhance mucoadhesion of econazole-loaded gelatin films for buccal drug delivery.

Luisa S Dolci1, Anna Liguori2, Silvia Panzavolta3, Anna Miserocchi2, Nadia Passerini1, Matteo Gherardi4, Vittorio Colombo4, Adriana Bigi5, Beatrice Albertini1.   

Abstract

In this paper we developed an innovative, effective and rapid one-step approach to crosslink mucoadhesive gelatin films for buccal drug delivery. The method, which involves the application of non-equilibrium pressure plasma for 3 or 5 minutes/side, was compared with a classical approach based on the use of a chemical crosslinking agent, namely genipin. Econazole nitrate (ECN), an imidazole antifungal agent used for the treatment of skin infections and mucosal candidiasis, was selected as model drug. X-Ray Diffraction characterization performed on the drug-containing gelatin films revealed that ECN undergoes to a topotactic transformation into Econazole (EC) immediately after mixing with gelatin suggesting the occurrence of an acid-base reaction between drug and gelatin during film processing. Plasma treatment, as well as genipin crosslinking, did not provoke any further variation of EC structure. However, plasma exposure significantly improved films adhesiveness and allowed to reach mucoadhesive strength values more than double with respect to those obtained with genipin, ascribable to the presence of polar and hydrophilic groups on the plasma treated film's surface. A residence time of at least 48 h was obtained by properly selecting the plasma exposure times. These results, together with the in-vitro data showing retention of antifungal efficacy against a strain of Candida albicans, demonstrated that plasma treatment was a valid and rapid alternative, easy to scale-up, to chemical crosslinking methods for the production of highly mucoadhesive gelatin-based films.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Econazole nitrate; Gelatin; Mucoadhesion; Non-equilibrium atmospheric pressure plasma; Surface modification

Mesh:

Substances:

Year:  2017        PMID: 29278802     DOI: 10.1016/j.colsurfb.2017.12.030

Source DB:  PubMed          Journal:  Colloids Surf B Biointerfaces        ISSN: 0927-7765            Impact factor:   5.268


  5 in total

1.  Electrospinning of Fish Gelatin Solution Containing Citric Acid: An Environmentally Friendly Approach to Prepare Crosslinked Gelatin Fibers.

Authors:  Anna Liguori; Jone Uranga; Silvia Panzavolta; Pedro Guerrero; Koro de la Caba; Maria Letizia Focarete
Journal:  Materials (Basel)       Date:  2019-09-01       Impact factor: 3.623

Review 2.  Mucoadhesive electrospun nanofibers for drug delivery systems: applications of polymers and the parameters' roles.

Authors:  Graciela Lizeth Pérez-González; Luis Jesús Villarreal-Gómez; Aracely Serrano-Medina; Erick José Torres-Martínez; José Manuel Cornejo-Bravo
Journal:  Int J Nanomedicine       Date:  2019-07-15

Review 3.  Drug delivery systems for oral disease applications.

Authors:  Yue Zhang; Ruining Jiang; Lei Lei; Yingming Yang; Tao Hu
Journal:  J Appl Oral Sci       Date:  2022-03-09       Impact factor: 2.698

Review 4.  Open Questions in Cold Atmospheric Plasma Treatment in Head and Neck Cancer: A Systematic Review.

Authors:  Vittoria Perrotti; Vito Carlo Alberto Caponio; Lorenzo Lo Muzio; Eun Ha Choi; Maria Carmela Di Marcantonio; Mariangela Mazzone; Nagendra Kumar Kaushik; Gabriella Mincione
Journal:  Int J Mol Sci       Date:  2022-09-06       Impact factor: 6.208

5.  A Modular Composite Device of Poly(Ethylene Oxide)/Poly(Butylene Terephthalate) (PEOT/PBT) Nanofibers and Gelatin as a Dual Drug Delivery System for Local Therapy of Soft Tissue Tumors.

Authors:  Anna Liguori; Alessandro De Vita; Giulia Rossi; Luisa Stella Dolci; Silvia Panzavolta; Chiara Gualandi; Laura Mercatali; Toni Ibrahim; Maria Letizia Focarete
Journal:  Int J Mol Sci       Date:  2022-03-17       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.